Bristol Myers Squibb said on Thursday the U.S. Food and Drug Administration (FDA) approved its oral heart disease drug Mavacamten, making it the first cardiac myosin inhibitor to be permitted for use in the country.
A woman holds test tube in front of displayed Bristol Myers Squibb logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustrationsaid on Thursday the U.S. Food and Drug Administration approved its oral heart disease drug Mavacamten, making it the first cardiac myosin inhibitor to be permitted for use in the country.
Hypertrophic cardiomyopathy is an inherited condition characterized by thickening of heart muscles, which is a common cause of sudden cardiac arrest in young people.About one in every 500 people in the United States suffers from hypertrophic cardiomyopathy, according to the American Heart Association, with a large portion having obstructive hypertrophic cardiomyopathy.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA Approves New Bristol-Myers Drug for Common Inherited Heart DiseaseU.S. health regulators approved a pill from Bristol-Myers Squibb, the first to treat a genetic heart disease that is the most common cause of sudden cardiac death in people under age 35.
Weiterlesen »
U.S. FDA pushes ahead with move to ban menthol cigarettesThe U.S. Food and Drug Administration issued a long-awaited proposal to ban menthol cigarettes and flavored cigars, a major victory for anti-smoking advocates but one that could face stiff opposition from Big Tobacco
Weiterlesen »
FDA proposes rule to ban menthol cigarettes and flavored cigarsThe FDA announced its proposed rules for the ban Thursday, to 'help prevent children from becoming the next generation of smokers,' said HHS Secretary Xavier Becerra.
Weiterlesen »
Moderna asks FDA to authorize first COVID-19 vaccine for very young childrenModerna announced Thursday that the company has asked the Food and Drug Administration to authorize a low-dose version of its COVID-19 vaccine as the first vaccine for children younger than age 5.
Weiterlesen »
FDA releases plan to ban menthol in cigarettes, cigarsThe Food and Drug Administration (FDA) released its plan to ban menthol cigarettes and flavored cigars on Thursday, saying the actions have the potential to significantly reduce disease and death.
Weiterlesen »
Moderna asks FDA to authorize first COVID-19 vaccine for very young childrenThe company says a low-dose version of its vaccine triggers an immune response in children ages 6 months to less than 6 years equivalent to what has protected older children and adults.
Weiterlesen »